Lars Lind

93.5k total citations · 5 hit papers
681 papers, 29.2k citations indexed

About

Lars Lind is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lars Lind has authored 681 papers receiving a total of 29.2k indexed citations (citations by other indexed papers that have themselves been cited), including 267 papers in Cardiology and Cardiovascular Medicine, 120 papers in Physiology and 97 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lars Lind's work include Cardiovascular Health and Disease Prevention (124 papers), Blood Pressure and Hypertension Studies (112 papers) and Heart Rate Variability and Autonomic Control (56 papers). Lars Lind is often cited by papers focused on Cardiovascular Health and Disease Prevention (124 papers), Blood Pressure and Hypertension Studies (112 papers) and Heart Rate Variability and Autonomic Control (56 papers). Lars Lind collaborates with scholars based in Sweden, United States and United Kingdom. Lars Lind's co-authors include Johan Sundström, Johan Ärnlöv, Peter Lind, Hans Lithell, Erik Ingelsson, Anders Larsson, Samira Salihović, Björn Zethelius, Sver­ker Ljunghall and Bert van Bavel and has published in prestigious journals such as Science, The Lancet and JAMA.

In The Last Decade

Lars Lind

670 papers receiving 28.4k citations

Hit Papers

Prognostic accuracy of day versus night ambulatory blood ... 2007 2026 2013 2019 2007 2009 2012 2014 2018 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study
    2007 660 citations Lars Lind et al. profile →
  2. Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
    2009 484 citations Johan Ärnlöv, Erik Ingelsson et al. profile →
  3. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data
    2012 407 citations Lars Lind, Michiel L. Bots et al. profile →
  4. The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer's disease
    2014 297 citations Lars Lind et al. profile →
  5. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
    2018 287 citations Lars Lind et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Lind Sweden 87 9.1k 4.9k 4.2k 3.9k 3.7k 681 29.2k
David S. Siscovick United States 107 15.0k 1.7× 6.4k 1.3× 4.3k 1.0× 5.1k 1.3× 7.3k 2.0× 598 49.9k
Eliseo Güallar United States 98 5.3k 0.6× 3.1k 0.6× 3.4k 0.8× 4.4k 1.1× 8.5k 2.3× 533 34.3k
George Howard United States 93 15.5k 1.7× 3.2k 0.6× 2.2k 0.5× 4.8k 1.2× 2.7k 0.7× 632 40.1k
Nosratola D. Vaziri United States 92 3.8k 0.4× 6.4k 1.3× 9.8k 2.3× 4.0k 1.0× 2.3k 0.6× 465 31.4k
Yuling Hong United States 55 9.7k 1.1× 3.7k 0.7× 2.0k 0.5× 3.2k 0.8× 6.6k 1.8× 136 29.8k
Hirotsugu Ueshima Japan 73 6.9k 0.8× 3.5k 0.7× 2.1k 0.5× 3.6k 0.9× 825 0.2× 567 19.6k
Rachel Huxley Australia 71 6.0k 0.7× 2.6k 0.5× 2.0k 0.5× 3.8k 1.0× 1.6k 0.4× 216 20.4k
John F. Keaney United States 92 8.8k 1.0× 9.0k 1.8× 6.3k 1.5× 2.8k 0.7× 871 0.2× 254 31.1k
Martha L. Daviglus United States 80 6.2k 0.7× 4.2k 0.8× 2.4k 0.6× 2.4k 0.6× 2.0k 0.5× 612 23.2k
Kiang Liu United States 100 13.5k 1.5× 5.3k 1.1× 2.0k 0.5× 5.8k 1.5× 1.1k 0.3× 488 39.1k

Countries citing papers authored by Lars Lind

Since Specialization
Citations

This map shows the geographic impact of Lars Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Lind more than expected).

Fields of papers citing papers by Lars Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Lind. The network helps show where Lars Lind may publish in the future.

Co-authorship network of co-authors of Lars Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Lind. A scholar is included among the top collaborators of Lars Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Lind. Lars Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michaëlsson, Karl, John A. Baron, Tove Fall, et al.. (2025). Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation. EBioMedicine. 113. 105580–105580. 1 indexed citations
2.
Karlsson, Per, Lars Lind, Karl Michaëlsson, & Andreï Malinovschi. (2024). Cardiopulmonary exercise testing and body composition. ERJ Open Research. 10(3). 970–2023.
3.
Ghosh, Nilanjana, Tomasz Czuba, Koen F. Dekkers, et al.. (2024). Analysis of plasma metabolomes from 11 309 subjects in five population-based cohorts. Scientific Reports. 14(1). 8933–8933. 2 indexed citations
4.
Dunder, Linda, Samira Salihović, Georgios Varotsis, et al.. (2023). Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease – Results from two independent population-based cohorts and a meta-analysis. Environment International. 181. 108250–108250. 19 indexed citations
5.
Fanelli, Giuseppe, Barbara Franke, Ward De Witte, et al.. (2022). Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders. Translational Psychiatry. 12(1). 59–59. 56 indexed citations
6.
Mendham, Amy E., Lisa K. Micklesfield, Fredrik Karpe, et al.. (2022). Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women. Diabetologia. 66(1). 174–189. 2 indexed citations
7.
Lind, Lars, Peter Lind, Margareta Halin Lejonklou, et al.. (2016). Uppsala Consensus Statement on Environmental Contaminants and the Global Obesity Epidemic. Environmental Health Perspectives. 124(5). A81–3. 32 indexed citations
8.
Ciuculete, Diana M., Christian Benedict, Gérard Waeber, et al.. (2016). A genetic risk score is significantly associated with statin therapy response in the elderly population. Clinical Genetics. 91(3). 379–385. 15 indexed citations
9.
Stubleski, Jordan, Samira Salihović, Lars Lind, et al.. (2016). Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort. Environment International. 95. 86–92. 56 indexed citations
10.
Lind, Lars, Johan Ärnlöv, Bertil Lindahl, et al.. (2015). Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis. Atherosclerosis. 242(1). 205–210. 110 indexed citations
11.
Kumar, Jitender, Peter Lind, Samira Salihović, et al.. (2014). Influence of persistent organic pollutants on oxidative stress in population-based samples. Chemosphere. 114. 303–309. 37 indexed citations
12.
Wallentin, Lars, Björn Zethelius, Lars Berglund, et al.. (2013). GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men. PLoS ONE. 8(12). e78797–e78797. 111 indexed citations
13.
Eggers, Kai M., Per Venge, & Lars Lind. (2013). Mid-regional pro-atrial natriuretic peptide levels in the elderly: Clinical and prognostic implications, and comparison to B-type natriuretic peptides. Clinica Chimica Acta. 419. 62–66. 14 indexed citations
14.
Lind, Lars, Sanne A. E. Peters, Hester M. den Ruijter, et al.. (2012). Effect of Rosuvastatin on the Echolucency of the Common Carotid Intima-Media in Low-Risk Individuals: The METEOR Trial. Journal of the American Society of Echocardiography. 25(10). 1120–1127.e1. 19 indexed citations
15.
Ingelsson, Erik, Lars Lind, Johan Ärnlöv, & Johan Sundström. (2006). Sleep Disturbances Independently Predict Heart Failure in Overweight Middle-Aged Men. European Journal of Heart Failure. 9(2). 184–190. 28 indexed citations
16.
17.
Ärnlöv, Johan, Johan Sundström, Lars Lind, et al.. (2005). hUNC-93B1, a Novel Gene Mainly Expressed in the Heart, is Related to Left Ventricular Diastolic Function, Heart Failure Morbidity and Mortality in Elderly Men. European Journal of Heart Failure. 7(6). 958–965. 2 indexed citations
18.
Ingelsson, Erik, Johan Ärnlöv, Johan Sundström, & Lars Lind. (2005). The Validity of a Diagnosis of Heart Failure in a Hospital Discharge Register. European Journal of Heart Failure. 7(5). 787–791. 359 indexed citations
19.
Schölin, Anna, Agneta Siegbahn, Lars Lind, et al.. (2004). CRP and IL‐6 concentrations are associated with poor glycemic control despite preserved β‐cell function during the first year after diagnosis of type 1 diabetes. Diabetes/Metabolism Research and Reviews. 20(3). 205–210. 34 indexed citations
20.
Lind, Lars & Bertil Andrén. (1998). [Left ventricular hypertrophy--an important, often unrecognized risk factor].. PubMed. 95(32-33). 3405–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David S. Siscovick Breakdown of academic impact, for papers by Eliseo Güallar Breakdown of academic impact, for papers by George Howard Breakdown of academic impact, for papers by Nosratola D. Vaziri Breakdown of academic impact, for papers by Yuling Hong Breakdown of academic impact, for papers by Hirotsugu Ueshima Breakdown of academic impact, for papers by Rachel Huxley Breakdown of academic impact, for papers by John F. Keaney Breakdown of academic impact, for papers by Martha L. Daviglus Breakdown of academic impact, for papers by Kiang Liu
Rankless by CCL
2026